Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prospective Clinical Evaluation of Three Prosthesis Re-Cap, M2a-Magnum and C2a-Taper.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006 by Frederiksberg University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Frederiksberg University Hospital
ClinicalTrials.gov Identifier:
NCT00284674
First received: January 31, 2006
Last updated: September 14, 2006
Last verified: September 2006
  Purpose

This evaluation is being conducted to evaluate the performance of thee prosthesis.


Condition Intervention Phase
Patients Undergoing a THR
Device: Hip prosthesis (re-cap, m2a-magnum and C2a-taper)
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label

Further study details as provided by Frederiksberg University Hospital:

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Good general health of age (ASA I-II)
  • DEXA-scanning: lower limit for a 55 years old man
  • MRI normal vitality in caput
  • Willing to return for follow-up evaluations
  • Exclusion Criteria:
  • Subjects displaying any of the following contra-indications shall be excluded from this evaluation:
  • Inability to co-operate with and complete the study
  • Collum < 2 cm
  • Large cysts in caput
  • Mismatch between caput acetabulum
  • Caput necrosis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00284674

Contacts
Contact: Arne Borgwardt, M.D. 004538163450 arne@borgwardt.com

Locations
Denmark
Frederiksberg University Hospital Recruiting
Copenhagen, Frederiksberg, Denmark, 2000
Contact: Arne Borgwardt, M.D.    004538163450    Arne@borgwardt.com   
Sponsors and Collaborators
Frederiksberg University Hospital
Investigators
Study Director: Arne Borgwardt, M.D. Frederiksberg University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00284674     History of Changes
Other Study ID Numbers: KF-01-287.591
Study First Received: January 31, 2006
Last Updated: September 14, 2006
Health Authority: Denmark: Ethics Committee

ClinicalTrials.gov processed this record on November 24, 2014